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stem cell self-renewal. One of the widely studied miRNA-protein regulators is the Lin28-Let-7 pair. In this study,
we demonstrate that contrary to the well-established models of mouse ES cells (mESC) and transformed human
cancer cells, the pluripotent state of human ES cells (hESC) involves expression of mature Let-7 family miRNAs
with concurrent expression of all LIN28 proteins. We show that mature Let-7 miRNAs are regulated during
hESC differentiation and have opposite expression proﬁle with LIN28B. Moreover, mature Let-7 miRNAs ﬁne
tune the expression levels of LIN28B protein in pluripotent hESCs, whereas silencing of LIN28 proteins have no
effect on mature Let-7 levels. These results bring novel information to the highly complex network of human
pluripotency and suggest that maintenance of hESC pluripotency differs greatly from the mESCs in regard to
LIN28-Let-7 regulation.





Human embryonic stem cell1. Introduction
The stem cells extracted from the inner cell mass of an embryo are
pluripotent, i.e. they have unique ability of long-term self-renewal and
the potential to develop into all specialized cell types (Evans and
Kaufman, 1981; Martin, 1981). However, embryonic stem cells with
different origins have different characteristics. Mouse and human em-
bryonic stem cells (mESCs and hESCs, respectively) are distinguished
for example, by their morphology, marker gene expression, and culture
requirements (Xue et al., 2011). Also, different pluripotent states of em-
bryonic cells have been identiﬁed in both species at different stages of
pre- and postimplantation embryos. Epiblast stem cells (EpiSC) (Brons
et al., 2007) from mouse postimplantation embryo are considered plu-
ripotent, however, but exhibit limited differentiation potential and the
characteristics more resemble hESCs than mESCs (Nichols and Smith,
2009; Tesar et al., 2007). It has been proposed that mESCs represent
the naïve, ground state pluripotency, whereas EpiSCs and hESCs are
primed pluripotent cells. Recent studies have also succeeded in estab-
lishing naïve human stem cell cultures that differ from hESCs and
have mESC characteristics (Chan et al., 2013; Gafni et al., 2013; Hanna
et al., 2010; Takashima et al., 2014; Theunissen et al., 2014; Ware etic Centre, Karolinska Institutet,
. This is an open access article underal., 2014), butmore closely resemble human preimplantation blastocyst
(Huang et al., 2014).
Micro RNAs (miRNA) are small non-coding RNA molecules acting
primarily in translational repression. Interestingly, different pluripotent
states can be discriminated by their miRNA proﬁles (Jouneau et al.,
2012; Neveu et al., 2010). The family of Let-7 miRNAs is highly
expressed in somatic cells, and repression of Let-7 is thought to be im-
portant in establishing the pluripotent state (Melton et al., 2010;
Viswanathan and Daley, 2010). Let-7 together with Lin28 has been re-
ported to form a bistable switch in mice and nematodes. This double
negative feedback loop is thought to stabilize and determine different
cellular fates, Lin28 in establishing the undifferentiated and Let-7 the
differentiated cell state (Shyh-Chang and Daley, 2013; Viswanathan
and Daley, 2010). Human LIN28 protein has two paralogs, LIN28A
(also LIN28) and LIN28B, and both have been shown to have a role in
pluripotency and cell reprogramming (Qiu et al., 2010; Yu et al., 2007;
Zhang et al., 2016). LIN28 proteins have also been shown to be impor-
tant in cancers and to inhibit Let-7 biogenesis. However, there is in-
creasing evidence that LIN28 proteins have also Let-7 independent
functions (Mayr and Heinemann, 2013; Shyh-Chang and Daley, 2013).
Here, we provide evidence that challenges the LIN28-Let-7 double
negative feedback-loop mechanism in human ES cells. We show that
mature Let-7 miRNAs are present and have a function in pluripotent
hESCs in ﬁnetuning the expression of LIN28B, and that silencing LIN28
proteins has no effect on mature Let-7 miRNAs.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Cell culture and differentiation series
H7, H9 (WiCell Research Institute, Madison, WI) and HS360 (Outi
Hovatta, Karolinska Institutet, Sweden) were used for experiments in
feeder free conditions on Matrigel (BD Biosciences) in mTeSR1 (Stem
Cell Technologies). Cells were passaged by using type IV collagenase
(Gibco) or Dispase (Stem Cell Technologies). Embryonal carcinoma
cell line NT2D1 (from Peter W. Andrews, University of Shefﬁeld, UK)
was grown in DMEM (Sigma) supplemented with 10% fetal calf serum
(FCS) (PromoCell) and 2 mM L-glutamine (Sigma). Spontaneous EB dif-
ferentiation series weremade by scraping the cells fromMatrigel plates
and transferring to non-coated cell culture plates. The cells were grown
in normal ES culture medium for 2–3 days, after which ES medium
without bFGF was added. Medium was changed every 2–3 days.
2.2. Flow cytometry and cell sorting
Pluripotent cell population was sorted using antibody against SSEA3
cell surface marker, details of the antibodies are given in Supplemental
information. Cells were harvested with trypsin. Sorting was performed
with BD FACSAria IIu cell sorter (BD) and FACSDiva Software.
2.3. RT-qPCR analysis
Total RNA was extracted using TRI Reagent (Molecular Research
Center Inc) and chloroform (Sigma-Aldrich). MaturemiRNAswere ana-
lyzed with Taqman MicroRNA Assays (listed in Supplemental informa-
tion), Taqman MicroRNA Reverse Transcription Kit (PA4366597) and
Taqman universalmastermix No AmpErase UNG (PN 4324018) accord-
ing to manufacturer's protocols (all from Applied Biosystems). For
mRNA analysis 1 μg of total RNAwas DNase treated twice [DNase I Am-
pliﬁcation Grade (Invitrogen)] and analyzed with reference gene EF1α
to conﬁrm no DNA was left in the sample. For cDNA synthesis Super-
script II (Invitrogen) was used. The primer and probe sequences were
designed using Universal ProbeLibrary Assay Design Center and are
listed in Supplemental information. MicroRNA and mRNA gene expres-
sion levelsweremeasured using the7900HT Fast Real-TimePCR System
(Applied Biosystems). Expression levels were normalized using house-
keeping genes. Change in threshold cycles (Ct) for each genewas calcu-
lated ΔCt = Ct(gene)− Ct(housekeeping gene). Relative expression to
control sample was calculated as fold change FC = (2−ΔCt).
2.4. Protein analyses
Protein analysiswas carried out as previously described (Narva et al.,
2011). The details of the antibodies are given in Supplemental
information.
2.5. Transfections, silencing and gain of function studies
Transfections were performed according to the manufacturer's pro-
tocols using Lipofectamine RNAiMax reagent (Invitrogen). Silencing of
miRNAs was performed with miRCURY LNA™ microRNA Inhibitors
(Exiqon). For gain of function studies Pre-miR miRNA Precursors
(Ambion, Life Technologies) were used according to manufacturer's
protocol. Oligonucleotides used in this study are listed in Supplemental
information.
2.6. Sequencing data analysis
Sequencing of samples was carried out at Fasteris (Switzerland). Se-
quences were mapped to the hg19 genome reference using bowtie
allowing for a maximum of two mismatches in the seed region (length
of 17 nt) and discarding reads that map to more than ﬁve genomiclocations. The alignments were then used as input to miRDeep2 to gen-
erate the coverage for mature microRNAs. Default parameter values
were used. In cases where a mature microRNA corresponded withmul-
tiple precursor microRNAs, only the counts from the precursor
microRNA with the highest number of mapped reads were included.
Reads per million microRNAs mapped (rpm) were obtained and aver-
aged for the three replicates. GEO accession number GSE55757.
3. Results and discussion
3.1. Mature Let-7 miRNAs are expressed in the pluripotent hESCs
Contrary to the studies of mESCs, we detected expression of all ma-
ture Let-7 miRNA family members in pluripotent hESCs in our genome
wide deep sequencing data (Supplementary material Table 1). The
pluripotency and differentiation associatedmiRNAs showed the expect-
ed expression proﬁles in the dataset (Morin et al., 2008; Suh et al.,
2004). We further validated the sequencing results in two different
hESC lines (HS360, H9) by using RT-qPCR designed to speciﬁcally detect
the mature miRNAs. Somatic ﬁbroblasts were used as a positive control
for Let-7 expression, andNT2D1 embryonal carcinoma cells (EC),malig-
nant counterparts of hESCs, as positive control for themiRNAs reported
to be expressed in pluripotent cells (Suh et al., 2004) (miR-302-367,
miR-21) (Fig. 1A). The RT-qPCR results conﬁrmed Let-7a, -b, -g and
pluripotency miRNAs were expressed in hESCs. The expressions of dif-
ferentiation induced miRNAs, miR-122 and miR-199a (Morin et al.,
2008), were low or undetectable as expected (Fig. 1A). Recent deep se-
quencing and microarray studies in fact supports our ﬁndings on ma-
ture Let-7 expression in pluripotent hESCs (Areﬁan et al., 2011;
Lakshmipathy et al., 2007; Letzen et al., 2010; Morin et al., 2008; Ren
et al., 2009; Stadler et al., 2010). Interestingly, we detected Let-7s to
be simultaneously expressed with hESC speciﬁc cell cycle regulating
(ESCC) miRNAs; miR-302b and -367 (Card et al., 2008; Lipchina et al.,
2011) whereas in mouse ES cells, ESCC orthologues and Let-7 miRNAs
are never co-expressed at high levels (Melton et al., 2010).
Pluripotent hES cells are relatively laborious to maintain in culture
and typically a proportion of spontaneously differentiating cells exist
in the cell population. As expression of mature Let-7 miRNAs has been
reported to increase during cell differentiation (Patterson et al., 2012;
Viswanathan et al., 2008) we wanted to exclude the possibility that
the expression ofmature Let-7 is coming from the spontaneously differ-
entiated cells existing in the cell population. Thereby, we sorted the
hESCs into pluripotent SSEA3+ (Draper et al., 2004) and spontaneously
differentiated SSEA3− cell populations (Fig. 1B). RT-qPCR analysis of
sorted cells revealed expression of mature Let-7 miRNAs in both
SSEA3+ and SSEA3− cells (Fig. 1C). Importantly, mature Let-7miRNAs
were co-expressed in SSEA3+ cells with both LIN28 proteins along
with pluripotency markers OCT4 and L1TD1 (Narva et al., 2011) (Fig.
1D,E). This was unexpected, since the Lin28 proteins have been shown
to inhibit the biogenesis of Let-7 miRNAs in mouse ES and EC cells and
in transformed human cell lines (Newman et al., 2008; Piskounova et
al., 2011; Viswanathan et al., 2008). In addition, the expressions of
LIN28A and LIN28B have been suggested to be mutually exclusive
(Piskounova et al., 2011) and the proteins are not co-expressed in sev-
eral human cancer cell lines (Viswanathan et al., 2009). Taken together,
our results demonstrate that mature Let-7 miRNAs are expressed and
co-exist with both LIN28 proteins in the pluripotent hESCs.
It has been demonstrated that hESCs resemble more EpiSCs than
mESCs (Brons et al., 2007; Tesar et al., 2007). Further, mESC and EpiSCs
express different sets of miRNAs and these cell types can be distin-
guished based on their miRNA proﬁles. Notably, higher levels of mature
Let-7, miR-302d and miR-367 expressions have been observed in EpiSC
than in mESCs (Jouneau et al., 2012). We examined the Let-7 levels in
the novel miRNA data on naïve and primed human ES cells (Sperber
et al., 2015). Remarkably, all Let-7 family members were expressed
both in naïve and primed human ES cells in the data of Sperber et al.
Fig. 1.Mature Let-7 miRNAs are expressed in pluripotent human embryonic stem cells. (a) Validation of the sequencing results using RT-qPCR. Representative averaged data of two
biological replicates of each cell line. Mean ± SD. Threshold cycle Ct, ΔCt = Ct(gene) − Ct(housekeeping gene) ND: not detected. Fib: ﬁbroblast cells. (b) Representative ﬂow
cytometric analysis of cell sorting based on SSEA3 surface marker. In the ﬁgure is the secondary antibody staining alone, staining of hESCs (HS360) with SSEA3 before and after
sorting. (c) RT-qPCR analysis of selected miRNAs in the SSEA3+ and SSEA3− populations. Averaged data is from three biological replicates (HS360). Mean ± SD. (d) Representative
protein expression analysis of the pluripotency factors in the sorted cell populations (e) RT-qPCR analysis of selected mRNAs in the SSEA3+ and SSEA3− hESC populations. Averaged
data is from two biological replicates (HS360). Mean ± SD.
500 N. Rahkonen et al. / Stem Cell Research 17 (2016) 498–503Interestingly, Let-7a expression is signiﬁcantly higher in primed hESCs
than in naïve hESCs, whereas all the other family members have an op-
posite expression pattern. This data suggests that the difference in Let-7
expression between mouse and human pluripotent cells might be due
to species-speciﬁc differences rather than the difference in the develop-
mental state of pluripotent cells.3.2. Mature Let-7 miRNAs are regulated and have opposite expression
proﬁles with LIN28B during hESC differentiation
After detecting the mature Let-7 miRNAs in pluripotent hESCs we
studied their expression in response to cell differentiation. In spontane-
ously differentiated hESCs the expressions of pluripotency markers
501N. Rahkonen et al. / Stem Cell Research 17 (2016) 498–503were signiﬁcantly lower (Fig. 2A, B, C). Analysis of Let-7 levels from the
same samples revealed the downregulation of Let-7a, -b, and -g, in the
ﬁrst stages of the embryonic body (EB) differentiation (until day 15),
followed by an increase in the expression in later time points (Fig.
2D). All analyzed family members had similar expression pattern.
Supporting our data, similar expression pattern of Let-7b and -i were
observed also in a study from Ren et al. (Ren et al., 2009). Interestingly,
during differentiation the expression of Let-7 miRNAs had the opposite
proﬁle of the LIN28B (Fig. 2A) that were ﬁrst upregulated until day 15,
followed by reduction after day 20when themiRNA levels started to in-
crease. Moreover, LIN28B isoforms 1 and 2 were regulated with differ-
ent kinetics. The mRNA level analysis of the same samples revealed
that the kinetics of LIN28B downregulation was slower than the reduc-
tions in OCT4 and LIN28A levels. LIN28B levels started to slowly decay
after day 10 and reduced 57% by day 25, whereasOCT4was signiﬁcantly
downregulated already on day 10 and was reduced 97% by day 25 (Fig.
2B). Importantly, LIN28Bwasnot signiﬁcantly induced atmRNA level al-
though upregulation was detected at the protein levels with both iso-
forms until day 15 and with LIN28B1 until day 25 of differentiation.
This indicates post-transcriptional regulation of the LIN28B protein ex-
pression, possibly by Let-7 miRNAs.
3.3. Let-7 miRNAs ﬁne tune the expression levels of LIN28B in pluripotent
hESCs
Next, we studied whether mature Let-7 miRNAs are functional in
hESCs and performed a series of loss- and gain of function studies. We
used LNA microRNA inhibitors for silencing (Let-7a independently, or
targeting the Let-7 family with 3 oligonucleotides) and Pre-miR
miRNA precursors (Let-7a) for induction. The effects were studied by
analysing expression levels of known or predicted targets of Let-7
miRNAs.
Silencing of Let-7 resulted in a clear increase in LIN28B protein
levels, while the effect on LIN28A was only moderate (Fig. 3A, B, C).
The effect on LIN28B expression was detected with all LNAFig. 2.Mature Let-7miRNAs are regulated and have opposite expression proﬁles with LIN28B p
analysis of the pluripotency factors in spontaneous embryoid body (EB) differentiation. LIN28
represent the quantitated protein expression compared to day 0 time point and balanced
differentiation. Averaged data from three replicate cultures (H9, HS360) Mean ± SD. **p b 0.
cell differentiation. Averaged data from two biological replicates (H9) Mean ± SD.oligonucleotides targeting the whole family of Let-7miRNAs. Consis-
tent with these results in public databases, (http://www.targetscan.
org/, http://www.microrna.org/) human LIN28B has four predicted
target sites for Let-7 miRNAs in its 3'UTR, while LIN28A has only
one. This suggests that in human cells, LIN28B is a stronger target
for Let-7 than LIN28A. The protein levels of pluripotency factors
OCT4 or L1TD1 were not consistently affected in response to Let-7 si-
lencing. Also, the analysis of mRNA levels from the samples did not
show signiﬁcant changes in the expression levels (data not shown).
Whereas silencing of Let-7 led to an increase in LIN28B protein
levels, induction of precursor Let-7a into the cells led to a decrease
in LIN28B protein expression as expected (Fig. 3F).
These results show Let-7 to have a function in hESCs in ﬁne tuning
the expression of at least LIN28B protein levels. Most likely Let-7
miRNAs have also several other targets in hESCs that remain to be
identiﬁed. Our results also show evidence that LIN28 proteins re-
spond differentially to the silencing and induction of Let-7 indicating
independent functions and differential roles for LIN28A and LIN28B
in hESCs. Moreover, these results suggest that the level of Let-7 in
hESCs needs to be tightly regulated to sustain the balance between
these factors.
3.4. Silencing of LIN28 proteins has no effect on mature Let-7 levels
Finally, we examined whether silencing of LIN28A or LIN28B, inde-
pendently or together, has an effect on mature Let-7 levels in hESCs.
The fact that LIN28 proteins and mature Let-7 miRNAs co-express in
these cells, suggests Let-7 independent functions. Supporting our previ-
ous observations and contrary to published results in mES cells
(Viswanathan et al., 2008; Viswanathan et al., 2009) we did not see
any effect on expression of mature Let-7a and Let-7g miRNAs in re-
sponse to LIN28 knockdowns (Fig. 3D, E). These results are in concor-
dance with several recent studies that have suggested Let-7
independent functions for LIN28 proteins in embryonic stem cells
(Cho et al., 2012; Peng et al., 2011; Shyh-Chang and Daley, 2013;roteins during human embryonic stem cell differentiation. (a) Representative protein level
B has two isoforms, longer LIN28B1 28 kDa and shorter LIN28B2 20 kDa. Numbers below
with β-actin (b) RT-qPCR analysis of OCT4, LIN28A, and LIN28B mRNAs in response to
01, ***p b 0.001. (c, d) RT-qPCR analysis of the levels of indicated miRNAs in response to
Fig. 3. Let-7miRNAs ﬁne tune LIN28B levels in pluripotent human embryonic stem cells but silencing of LIN28 proteins does not have an effect onmature Let-7 levels. (a) Representative
western blot analysis of LNA silencing of Let-7a and control (H7). Numbers represent the relative protein expression levels compared to the control sample and balancedwith β-actin. Day
1 timepoint. (b) Representativewestern blot analysis of indicatedproteins in response to silencing of Let-7 familywith three different LNAoligonucleotides (H9). (c) Averaged quantitated
differences in the protein level expression of indicatedproteins in response to Let-7a silencingwith LNA oligonucleotide from two biological replicates (H7,H9). (d) Representative protein
level analysis of LIN28A and LIN28B in response to silencing of LIN28A, B or both (H9). Numbers below represent the quantitated protein expression compared to non-targeted (NT) siRNA
sample balancedwith KU70. (e) RT-qPCR analysis of Let-7a and Let-7 g levels in response to silencing of LIN28A, B, or both in hESCs. Averaged data is from three biological replicates (H7,
H9, HS360). Mean ± SD. (f) Representative protein level analysis of indicated proteins in response to introduction of Precursor Let-7a into hESCs (H9) on day 2 time point. Numbers
represent the relative protein expression compared to the control sample and balanced with β-actin.
502 N. Rahkonen et al. / Stem Cell Research 17 (2016) 498–503Wilbert et al., 2012). The alternative role for LIN28 proteins has been
shown to be in translational regulation of messenger RNAs (Hafner et
al., 2013; Peng et al., 2011; Wilbert et al., 2012). Interestingly however,
a recent study (Triboulet et al., 2015) reported a single Let-7 to bypass
LIN28 mediated repression in human cancer cells. This observation
brings further intricacy to LIN28-Let7 axis in development and disease,
and underlines the complexity of these interactions and regulation.
Moreover, even though our transient silencing with siRNA is efﬁcient
and we do not see an effect on mature Let-7 levels even after double
knockdown of LIN28, there is still a possibility that the residual LIN28
protein is sufﬁcient to regulate Let-7 biogenesis.
3.5. Conclusions
In summary, our data shows that the pluripotent state of hESCs in-
volves concurrent expression of LIN28 proteins and Let-7 miRNAs. Fur-
ther, Let-7 miRNAs have a function in hESCs in ﬁne tuning LIN28B
protein levels. We suggest that maintenance of hESC pluripotency differ
greatly from themESCs in regard to LIN28-Let-7 expression proﬁles and
interactions and that hESCs lack the double negative feedback loop
formed by LIN28-Let-7. How this LIN-Let-7 pair function in naïve
hESCs or EpiSCs remains to be studied. Analysing all the stem cell
types would be needed to shed light if the results reported here are
due to a difference in the developmental state of the cells or due to spe-
cies-speciﬁc difference. Nonetheless, these results bring novel aspects to
the complex network of pluripotency.Funding
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